BioNTech Competitors
| 22UA Stock | | | EUR 93.80 1.60 1.74% |
BioNTech SE competes with
Genmab A/S,
Moderna, and
Novavax; as well as few others. The company operates under
Biotechnology sector and is part of
Health Care industry. Analyzing BioNTech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of BioNTech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out
BioNTech Correlation with its peers.
BioNTech vs CureVac NV Correlation
Excellent diversification
The correlation between BioNTech SE and 5CV is -0.66 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and 5CV in the same portfolio, assuming nothing else is changed.
The BioNTech's current
Return On Tangible Assets is estimated to increase to -0.03. The BioNTech's current
Return On Capital Employed is estimated to increase to -0.06. At this time, BioNTech's
Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The BioNTech's current
Other Current Assets is estimated to increase to about 256.8
M, while
Debt To Assets are projected to decrease to 0.01.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BioNTech. Your research has to be compared to or analyzed against BioNTech's peers to derive any actionable benefits. When done correctly, BioNTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BioNTech SE.
BioNTech Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between BioNTech and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of BioNTech and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of BioNTech SE does not affect the price movement of the other competitor.
High positive correlations | | High negative correlations |
Risk-Adjusted IndicatorsThere is a big difference between BioNTech Stock performing well and BioNTech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioNTech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
BioNTech Competitive Analysis
The better you understand BioNTech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, BioNTech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across BioNTech's competition over several years is one of the best ways to analyze its investment potential.
BioNTech Competition Performance Charts
Five steps to successful analysis of BioNTech Competition
BioNTech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by BioNTech SE in relation to its competition. BioNTech's competition analysis typically involves several steps, including:
- Identifying the key players in the market: This involves identifying the major competitors of BioNTech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact BioNTech's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to BioNTech SE, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.
Complement your BioNTech position
In addition to having BioNTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can
partner with us for reliable portfolio optimization as you plan to utilize
Realty Funds Theme or any other
thematic opportunities.
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock: Understanding that BioNTech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether BioNTech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
